Theodoros Foukakis Selected Research

Theodoros Foukakis Research Topics

Disease

47	Breast Neoplasms (Breast Cancer) 05/2024 - 10/2013
37	Neoplasms (Cancer) 05/2024 - 09/2003
5	Neoplasm Metastasis (Metastasis) 07/2022 - 06/2007
4	Carcinoma (Carcinomatosis) 10/2019 - 10/2010
3	Carcinogenesis 01/2024 - 09/2003
3	Triple Negative Breast Neoplasms 09/2021 - 01/2018
3	Adenoma (Adenomas) 04/2012 - 09/2003
3	Thyroid Neoplasms (Thyroid Cancer) 04/2012 - 09/2003
2	Neutropenia 11/2023 - 01/2020
2	Hypoxia (Hypoxemia) 11/2017 - 08/2015
2	Papillary Carcinoma 04/2012 - 10/2010
2	Papillary Thyroid Cancer 04/2012 - 10/2010
2	follicular Thyroid cancer 10/2008 - 03/2006
2	Anaplastic Thyroid Carcinoma 09/2008 - 09/2003
2	Follicular Adenocarcinoma 06/2007 - 09/2003
1	Overweight 11/2023
1	Lymphatic Metastasis 01/2022
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Pathologic Complete Response 01/2021
1	Death (Near-Death Experience) 06/2020
1	Fatigue 05/2020
1	Leukopenia 01/2020
1	Febrile Neutropenia 01/2020
1	Infections 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Disease Progression 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2017
1	Unilateral Breast Neoplasms 10/2016
1	Amenorrhea 10/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2014

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 05/2024 - 10/2010
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2012
7	Hormones (Hormone)IBA 12/2023 - 11/2016
7	Docetaxel (Taxotere)FDA Link 01/2023 - 08/2015
5	Messenger RNA (mRNA)IBA 01/2024 - 01/2006
4	Trastuzumab (Herceptin)FDA Link 01/2024 - 01/2020
4	Estrogen ReceptorsIBA 07/2022 - 12/2017
4	B7-H1 AntigenIBA 09/2021 - 01/2019
4	Epirubicin (Ellence)FDA LinkGeneric 05/2020 - 01/2018
3	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2017
3	LigandsIBA 01/2024 - 01/2018
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2020 - 01/2020
3	RacivirIBA 10/2008 - 03/2006
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2024 - 12/2023
2	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2024 - 11/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	pertuzumabIBA 01/2023 - 01/2021
2	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 05/2020 - 01/2020
2	Letrozole (Femara)FDA LinkGeneric 03/2020 - 01/2019
2	Cyclin D1IBA 01/2019 - 09/2008
2	Bevacizumab (Avastin)FDA Link 01/2018 - 11/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 11/2017
2	Estrogens (Estrogen)FDA Link 10/2016 - 10/2013
1	Indicators and Reagents (Reagents)IBA 01/2024
1	thymidine kinase 1IBA 01/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	human ERBB2 proteinIBA 01/2024
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2024
1	Immunoconjugates (Immunoconjugate)IBA 12/2023
1	palbociclibIBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2021
1	Vitamin K FDA Link 01/2021
1	Vitamin K 2 (Vitamin K2)IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2020
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	Drug CombinationsIBA 06/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	ribociclibIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Erythropoietin FDA Link 11/2017
1	PeriostinIBA 11/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2016
1	Sunitinib (Sutent)FDA Link 01/2016
1	Angiogenesis InhibitorsIBA 01/2016
1	eribulin FDA Link 04/2015
1	taxaneIBA 04/2015
1	Cytostatic AgentsIBA 09/2014

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2024 - 10/2016
10	Therapeutics 01/2024 - 10/2013
8	Neoadjuvant Therapy 05/2024 - 04/2017
8	Adjuvant Chemotherapy 07/2022 - 11/2016
4	Immunotherapy 01/2023 - 01/2018
2	Radiotherapy 03/2021 - 01/2020
2	Segmental Mastectomy (Lumpectomy) 03/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 04/2018 - 09/2014
1	Resistance Training 01/2020
1	Palliative Care (Palliative Therapy) 11/2016
1	Mastectomy (Mammectomy) 10/2016
1	Aftercare (After-Treatment) 01/2016